Waddell & Reed Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-63,900
| Closed | -$1.59M | – | 560 |
|
|
2018
Q3 | $1.59M | Hold |
63,900
| – | – | ﹤0.01% | 519 |
|
|
2018
Q2 | $1.75M | Hold |
63,900
| – | – | ﹤0.01% | 514 |
|
|
2018
Q1 | $1.97M | Hold |
63,900
| – | – | ﹤0.01% | 492 |
|
|
2017
Q4 | $2.28M | Sell |
63,900
-140,750
| -69% | -$5.03M | 0.01% | 490 |
|
|
2017
Q3 | $5.64M | Sell |
204,650
-19,250
| -9% | -$530K | 0.01% | 458 |
|
|
2017
Q2 | $5.91M | Sell |
223,900
-11,100
| -5% | -$293K | 0.01% | 473 |
|
|
2017
Q1 | $4.89M | Sell |
235,000
-15,000
| -6% | -$312K | 0.01% | 481 |
|
|
2016
Q4 | $5.18M | Sell |
250,000
-50,000
| -17% | -$1.04M | 0.01% | 485 |
|
|
2016
Q3 | $4.86M | Hold |
300,000
| – | – | 0.01% | 520 |
|
|
2016
Q2 | $4.08M | Sell |
300,000
-53,850
| -15% | -$732K | 0.01% | 512 |
|
|
2016
Q1 | $6.18M | Sell |
353,850
-217,000
| -38% | -$3.79M | 0.01% | 457 |
|
|
2015
Q4 | $19.5M | Buy |
570,850
+194,700
| +52% | +$6.65M | 0.03% | 319 |
|
|
2015
Q3 | $11.2M | Buy |
376,150
+65,800
| +21% | +$1.96M | 0.02% | 392 |
|
|
2015
Q2 | $9.93M | Sell |
310,350
-25,000
| -7% | -$800K | 0.01% | 434 |
|
|
2015
Q1 | $6.95M | Sell |
335,350
-13,700
| -4% | -$284K | 0.01% | 472 |
|
|
2014
Q4 | $5.91M | Sell |
349,050
-27,100
| -7% | -$459K | 0.01% | 475 |
|
|
2014
Q3 | $7.27M | Sell |
376,150
-4,526
| -1% | -$87.5K | 0.01% | 451 |
|
|
2014
Q2 | $12.9M | Sell |
380,676
-149,081
| -28% | -$5.07M | 0.02% | 397 |
|
|
2014
Q1 | $16.7M | Buy |
+529,757
| New | +$16.7M | 0.03% | 358 |
|